The Safety and Immunogenicity Following a Heterologous Booster Dose of Recombinant SARS-CoV-2 Vaccine LYB002
Clinical trial NCT05928468 · UNKNOWN
Trial details
- NCT number
- NCT05928468
- Sponsor
- Guangzhou Patronus Biotech Co., Ltd.
- Status
- UNKNOWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-25
- Primary completion
- 2023-07-31
- Enrollment
- 210
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.